Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
LSD
amphetamine Hallucinogen |
| gptkbp:CASNumber |
1354631-77-6
|
| gptkbp:chemicalFormula |
C18H23NO3
|
| gptkbp:discoveredBy |
2011
|
| https://www.w3.org/2000/01/rdf-schema#label |
25E-NBOMe
|
| gptkbp:IUPACName |
2-(4-ethyl-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
|
| gptkbp:legalStatus |
illegal in the United Kingdom
Schedule I in Canada illegal in Sweden |
| gptkbp:mechanismOfAction |
5-HT2A receptor agonist
|
| gptkbp:molecularWeight |
301.38 g/mol
|
| gptkbp:otherName |
2C-E-NBOMe
N-(2-methoxybenzyl)-2C-E NBOMe-2C-E |
| gptkbp:relatedTo |
gptkb:2C-E
gptkb:25I-NBOMe |
| gptkbp:routeOfAdministration |
sublingual
nasal buccal |
| gptkbp:bfsParent |
gptkb:NBOMe_series
|
| gptkbp:bfsLayer |
7
|